C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/1997
11/06/1997	WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
11/06/1997	WO1997041232A1 Antagonists of interleukin-15
11/06/1997	CA2252557A1 Antagonists of interleukin-15
11/05/1997	EP0804728A1 Assay, receptor proteins and ligands
11/05/1997	EP0804597A1 Activation of t-cells by modified, antigenic immunoglobulins
11/05/1997	EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
11/05/1997	EP0804579A1 Antibodies which bind to insect gut proteins and their use
11/05/1997	EP0804572A1 Protein tyrosine kinase agonist antibodies
11/05/1997	EP0804568A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
11/05/1997	EP0804565A1 Tetracycline-regulated transcriptional modulators
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
11/05/1997	EP0804487A2 Bispecific antigen-binding molecules
11/05/1997	EP0804482A1 Cytokines that bind the cell surface receptor hek
11/05/1997	EP0804219A1 Inhibin compositions and methods of use thereof
11/05/1997	EP0804215A1 Template assembled synthetic protein
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5683887 Immunochemical detection of in vivo advanced glycosylation endproducts
10/1997
10/30/1997	WO1997040154A1 Type c lectins
10/30/1997	WO1997040153A1 Al-2 neurotrophic factor
10/30/1997	WO1997040063A2 Pathogenic escherichia coli associated protein espa
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2250431A1 Al-2 neurotrophic factor
10/29/1997	EP0803574A2 Retrovirus-mediated secretion of recombinant products
10/29/1997	EP0548191B1 Separation of proteins and dyes
10/28/1997	US5681810 Diphtheria toxin fragments, conjugates and methods of use to inhibit tumors and leukemia
10/28/1997	US5681721 Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect
10/28/1997	CA1339515C Diagnostic system for the detection of cytomegalovirus
10/23/1997	WO1997039131A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997	WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997	WO1997026918A3 Ligand directed enzyme prodrug therapy
10/23/1997	WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997	WO1997021812A3 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/23/1997	CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997	CA2250975A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/22/1997	EP0491033B1 Isolation and purification of lung surfactant protein
10/21/1997	US5679880 Oral immunization by transgenic plants
10/21/1997	US5679546 Chimeric proteins which block complement activation
10/16/1997	WO1997038293A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto
10/16/1997	WO1997038127A1 Interaction trap systems for detecting protein interactions
10/16/1997	CA2251593A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto
10/15/1997	EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/14/1997	US5677432 Immunological detection of organophosphates
10/14/1997	US5677274 Anthrax toxin fusion proteins and related methods
10/14/1997	US5677180 Chimeric antibody with specificity to human B cell surface antigen
10/14/1997	US5677171 Inhibit growth of sk-br-3 breast tumor cells
10/14/1997	US5677148 Genetic engineering
10/14/1997	US5677147 HIV-2 virus variants
10/09/1997	WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	CA2248550A1 Cytokine designated lerk-8
10/09/1997	CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997	EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/07/1997	US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997	US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997	US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/02/1997	WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	WO1997035887A1 Precursors of catalytic antibodies
10/02/1997	WO1997035873A2 Peptides with antiproliferative properties
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997	DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997	CA2251691A1 Peptides with antiproliferative properties
10/02/1997	CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249455A1 Precursors of catalytic antibodies
10/01/1997	EP0798378A2 Estrogen receptor
10/01/1997	EP0797582A1 Phosphotyrosine assay and peptides for use therein
09/1997
09/30/1997	US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins
09/30/1997	US5672480 Immunoassays for prostate specific antigen
09/30/1997	US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected
09/25/1997	WO1997035024A1 Enzyme combinations for destroying proliferative cells
09/25/1997	WO1997034927A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
09/25/1997	WO1997012043A3 Hcv ns3 protein fragments having helicase activity and improved solubility
09/25/1997	CA2248629A1 Enzymes combinations for destroying proliferative cells
09/25/1997	CA2242342A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
09/24/1997	EP0796335A1 Production of peptides using recombinant fusion protein constructs
09/24/1997	EP0796334A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof
09/24/1997	EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/24/1997	EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1
09/24/1997	EP0796273A1 Variants of human papilloma virus antigens
09/24/1997	EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region
09/23/1997	US5670625 Cell surface protein
09/18/1997	WO1997033995A2 Extracellular matrix signalling molecules
09/18/1997	WO1997033913A1 Cytokine-receptor expressed in testis cells
09/18/1997	WO1997033912A2 Uses of gdnf and gdnf receptor
09/18/1997	WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
09/18/1997	DE19608813A1 Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen Conjugate for influencing protein-protein interactions
09/18/1997	CA2248549A1 Extracellular matrix signalling molecules
09/18/1997	CA2247805A1 Expression and secretion of heterologous polypeptides from caulobacter
09/18/1997	CA2246768A1 Uses of gdnf and gdnf receptor
09/16/1997	US5668256 Chimeric interleukin 5-receptor/immunoglobulin polypeptides
09/16/1997	US5667992 Mammalian expression systems for HCV proteins
09/16/1997	CA1339464C ¬leu13\| motilin, dnas coding for same and methods for producing same
09/13/1997	CA2175549A1 Expression and secretion of heterologous polypeptides from caulobacter

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 295